Αποτελέσματα Αναζήτησης
19 Μαΐ 2023 · In this review, we will discuss evidence-based risk assessment and decision tools for older men with prostate cancer, highlight intervention strategies to improve treatment tolerance, and contextualize these tools within the current treatment landscape for prostate cancer.
In 2010, the International Society of Geriatric Oncology (SIOG) developed treatment guidelines for men with prostate cancer who are older than 70 years old. In 2013, a new multidisciplinary SIOG working group was formed to update these recommendations.
4 Ιουν 2024 · Prostate cancer treatment may be different when you’re elderly. Here’s what to know about diagnosis, treatments, and survival rates if you’re 70 or older.
To update the 2014 International Society of Geriatric Oncology (SIOG) guidelines on prostate cancer in men aged >70 yr. The update includes new material on health status evaluation and the treatment of localised, advanced, and castrate-resistant disease.
19 Ιουλ 2022 · Castration-resistant prostate cancer: Treatments targeting the androgen pathway; Chemotherapy in advanced castration-resistant prostate cancer; Comprehensive geriatric assessment for patients with cancer; External beam radiation therapy for localized prostate cancer; Follow-up surveillance after definitive local treatment for prostate cancer
25 Μαΐ 2021 · A secondary analysis of the CHAARTED trial based on age showed an overall survival benefit with the addition of docetaxel to androgen-deprivation therapy in patients with metastatic hormone-sensitive prostate cancer. 9 Patients aged ≥ 70 (n = 177, 22.4%) had improved overall survival (HR = 0.45, 95% CI = 0.25–0.80) comparable to patients aged < 70.
1 Μαΐ 2017 · In the recently released European Randomized Study of Screening for Prostate cancer (ERSPC) trial, there was no benefit to screening men age 70 or older, although no screening study has been specifically restricted to elderly patients only. 12 Because subgroup analyses of cohorts included in large trials cannot provide the quality of evidence ne...
